American Century Companies’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.1M | Buy |
1,090,134
+62,646
| +6% | +$2.71M | 0.03% | 702 |
|
|
2025
Q1 | $35.5M | Buy |
1,027,488
+11,760
| +1% | +$407K | 0.02% | 769 |
|
|
2024
Q4 | $27.9M | Buy |
1,015,728
+88,882
| +10% | +$2.44M | 0.02% | 897 |
|
|
2024
Q3 | $23.6M | Sell |
926,846
-169,888
| -15% | -$4.33M | 0.01% | 953 |
|
|
2024
Q2 | $27.8M | Buy |
1,096,734
+182,623
| +20% | +$4.63M | 0.02% | 810 |
|
|
2024
Q1 | $28.3M | Buy |
914,111
+442,245
| +94% | +$13.7M | 0.02% | 790 |
|
|
2023
Q4 | $19M | Buy |
471,866
+163,574
| +53% | +$6.6M | 0.01% | 894 |
|
|
2023
Q3 | $8.13M | Buy |
308,292
+297,167
| +2,671% | +$7.84M | 0.01% | 1144 |
|
|
2023
Q2 | $191K | Buy |
11,125
+280
| +3% | +$4.82K | ﹤0.01% | 2537 |
|
|
2023
Q1 | $186K | Sell |
10,845
-125
| -1% | -$2.14K | ﹤0.01% | 2440 |
|
|
2022
Q4 | $83.6K | Sell |
10,970
-325,456
| -97% | -$2.48M | ﹤0.01% | 2482 |
|
|
2022
Q3 | $3.34M | Buy |
336,426
+3,058
| +0.9% | +$30.4K | ﹤0.01% | 1260 |
|
|
2022
Q2 | $3.03M | Sell |
333,368
-3,164
| -0.9% | -$28.7K | ﹤0.01% | 1290 |
|
|
2022
Q1 | $3.42M | Buy |
336,532
+130,465
| +63% | +$1.32M | ﹤0.01% | 1229 |
|
|
2021
Q4 | $3.44M | Sell |
206,067
-53,349
| -21% | -$890K | ﹤0.01% | 1162 |
|
|
2021
Q3 | $12.2M | Sell |
259,416
-408
| -0.2% | -$19.1K | 0.01% | 790 |
|
|
2021
Q2 | $15.8M | Buy |
259,824
+11,026
| +4% | +$672K | 0.01% | 716 |
|
|
2021
Q1 | $15.3M | Sell |
248,798
-4,067
| -2% | -$251K | 0.01% | 695 |
|
|
2020
Q4 | $18M | Buy |
252,865
+29,898
| +13% | +$2.13M | 0.01% | 642 |
|
|
2020
Q3 | $8.37M | Buy |
222,967
+26,726
| +14% | +$1M | 0.01% | 743 |
|
|
2020
Q2 | $6.4M | Buy |
+196,241
| New | +$6.4M | 0.01% | 747 |
|